138 related articles for article (PubMed ID: 7191082)
1. Interaction of genetics and separation in canine hyperkinesis and in differential responses to amphetamine.
Corson SA; Corson EO; Becker RE; Ginsburg BE; Trattner A; Connor RL; Lucas LA; Panksepp J; Scott JP
Pavlov J Biol Sci; 1980; 15(1):5-11. PubMed ID: 7191082
[No Abstract] [Full Text] [Related]
2. Clinical utility of animal models of childhood hyperkinesis.
Camp JA; Winsberg BG
Clin Neuropharmacol; 1984; 7(3):185-221. PubMed ID: 6149019
[No Abstract] [Full Text] [Related]
3. Pharmacological and biochemical aspects of hyperkinetic disorders.
Leonard BE
Neuropharmacology; 1979 Dec; 18(12):923-9. PubMed ID: 43483
[No Abstract] [Full Text] [Related]
4. Psychopharmacologic facilitation of psychosocial therapy of violence and hyperkinesis.
Corson SA; Corson EO
Act Nerv Super (Praha); 1988 Jan; 30(1):22-39. PubMed ID: 2898193
[TBL] [Abstract][Full Text] [Related]
5. Levoamphetamine and dextroamphetamine: differential effect on aggression and hyperkinesis in children and dogs.
Arnold LE; Kirilcuk V; Corson SA; Corson EO
Am J Psychiatry; 1973 Feb; 130(2):165-70. PubMed ID: 4568123
[No Abstract] [Full Text] [Related]
6. Canine hyperkinesis.
Campbell WE
Mod Vet Pract; 1974 Apr; 55(4):313-6. PubMed ID: 4856846
[No Abstract] [Full Text] [Related]
7. Lead-induced behavioral dysfunction: an animal model of hyperactivity.
Silbergeld EK; Goldberg AM
Exp Neurol; 1974 Jan; 42(1):146-57. PubMed ID: 4856900
[No Abstract] [Full Text] [Related]
8. Amphetamine controls.
Akins K
Can Med Assoc J; 1972 Jul; 107(2):113. PubMed ID: 5064963
[No Abstract] [Full Text] [Related]
9. Biochemical and behavioural effect of amphetamine in DMI and Ro 4-1284 induced hyperactivity.
Ladisich W; Volbehr H; Matussek N
Act Nerv Super (Praha); 1970 Jan; 12(1):83-4. PubMed ID: 5461497
[No Abstract] [Full Text] [Related]
10. Learning disorders, hyperkinesis, and the use of drugs in children.
Oettinger L
Rehabil Lit; 1971 Jun; 32(6):162-7 contd. PubMed ID: 5580199
[No Abstract] [Full Text] [Related]
11. Proceedings: Pemoline in comparison with amphetamine and placebo in pedo-psychiatric practice.
Cerný L; Kucerová Z; Sturma J
Act Nerv Super (Praha); 1975; 17(4):300-1. PubMed ID: 1221809
[No Abstract] [Full Text] [Related]
12. Hyperkinetic adult. Study of the "paradoxical" amphetamine response.
Arnold LE; Strobl D; Weisenberg A
JAMA; 1972 Nov; 222(6):693-4. PubMed ID: 4677899
[No Abstract] [Full Text] [Related]
13. The use of amphetamines in hyperactivity.
Oettinger L
Dev Med Child Neurol; 1975 Feb; 17(1):117. PubMed ID: 1091523
[No Abstract] [Full Text] [Related]
14. Use of d-amphetamine and related central nervous system stimulants in children.
Pediatrics; 1973 Feb; 51(2):302-5. PubMed ID: 4695865
[No Abstract] [Full Text] [Related]
15. Amphetamines in hyperkinetic children.
Tec L; Levy HB
JAMA; 1971 Jun; 216(11):1864-5. PubMed ID: 5108576
[No Abstract] [Full Text] [Related]
16. The use of stimulant drugs in treating hyperactive children.
Children; 1971; 18(3):111. PubMed ID: 5575695
[No Abstract] [Full Text] [Related]
17. Mood-altering drugs.
Turner EJ; Arnold LE
Pediatrics; 1971 Sep; 48(3):496-7. PubMed ID: 5094361
[No Abstract] [Full Text] [Related]
18. Hyperkineticism in children.
IMJ Ill Med J; 1970 Dec; 138(6):618. PubMed ID: 4395617
[No Abstract] [Full Text] [Related]
19. [Stimulants in the treatment of hyperkinetic behavior disorders].
Barkai A
Harefuah; 1971 Mar; 80(6):298-302. PubMed ID: 4946564
[No Abstract] [Full Text] [Related]
20. [Amphetamines in the treatment of hyperactive and instable children].
Glós J
Cesk Pediatr; 1973 Oct; 28(10):559-60. PubMed ID: 4766681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
